Advantageous salts of μ-opiate receptor peptides
AssigneeCytogel Pharma, LLC
InventorTheodore E Maione
Life of this patent
Estimating the term…
Abstract
The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.
Claims7
A peptide salt wherein the peptide has a sequence selected from SEQ ID NOs:
- 1-26 and the salt is aspartate.
A pharmaceutical composition comprising a peptide salt wherein the peptide has a sequence selected from SEQ ID NOs:
- 1-26 and the salt is aspartate.
A method for treating a condition that is modulated by μ-opiate receptor activity, wherein said method comprises administering, to a patient in need of such treatment a peptide salt wherein the peptide has a sequence selected from SEQ ID NOs:
- 1-26 and the salt is aspartate.
Dependencies are inferred from the claim text.